Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 -

Staff Report & Agenda Item Details

Request for approval of a Public Health or Safety Exemption from the competitive bid requirements with Merck & Co., Inc. d/b/a Merck Sharp & Dohme LLC; GlaxoSmithKline Holdings (Americas) Inc. d/b/a GlaxoSmithKline LLC; and Sanofi Vaccines US Inc. in the amount of $1,600,000 for various vaccines for the Refugee Health Screening Program for Public Health Services for the period of October 1, 2026 - September 30, 2027 using grant funds provided by the U.S. Department of Health and Human Services Refugee Medical Assistance Program.

This motion is scored as RESTRAINS_GOVERNMENT (Impact Weight: 5.1/10). Under the Bastiat Liberty Watchdog Index, voting YES on measures that cap or reduce ad valorem tax burdens, expand taxpayer exemptions, retire debt early, enforce competitive bidding caps, or remove regulatory/zoning barriers to private property rights earns a positive Pro-Liberty score.